| S.No |
Name |
Thesis title |
Completion year |
Present status |
| 1 |
Dr. Almesh Kadakol
(Supervisor)
|
Role of angiotensin II on vascular epigenetics in the development of atherosclerosis and therapeutic intervention of esculetin under type 2 diabetic conditions associated with renal failure |
23rd April 2018 |
Therapy Lead, MedTech & Lead MSL, Oncology, Alkem Laboratories Ltd., Mumbai |
| 2 |
Dr. Santosh Kumar Goru
(Supervisor)
|
Role of histone ubiquitination and ACE2 activation in the progression of renal fibrosis in type I diabetic kidney |
9th Jan 2018 |
Community Pharmacist
New Brunswick, Loblaw companies Limited, Canada |
| 3 |
Dr. Anuradha Pandey
(Supervisor) |
Role of epigenetics in modulating inflammatory response mediated by NF-kB through AT1 or AT2 receptor in the development of renal failure under type II diabetic condition |
21st March 2018 |
Senior medical writer, Indegene Ltd, Bengaluru |
| 4 |
Dr. Vajir Malek
(Supervisor) |
Role of neprilysin in the development of cardiovascular and renal complications associated with type 1 diabetes |
5th Feb 2020 |
Postdoctoral fellow, Beckman Research Institute, City of Hope, California, United States |
| 5 |
Dr. Nisha Sharma
(Supervisor) |
Involvement of histone H3 methylation, angiotensin converting enzyme 2, and angiotensin II type 2 receptor in the pathogenesis of acute kidney injury under type 1 diabetic and non-diabetic conditions |
22nd Oct 2020 |
Postdoctoral fellow, Arthur Riggs Diabetes Metabolism Research Institute, City of Hope, California, United States |
| 6 |
Dr. Himanshu Sankrityayan (Supervisor)
|
Understanding the role and regulation of endoplasmic stress in the development of endothelial dysfunction and kidney disease under type 1 diabetic condition |
27th Sept 2022 |
Medical Science Liaison (Ophthalmology), North India, Bayer Zydus Pharmaceuticals Pvt. Ltd., Delhi |
| 7 |
Dr. Ajinath Kale
(Supervisor) |
Klotho regulation as a novel therapeutic strategy against acute kidney injury-diabetes comorbidity |
4th Aug 2023 |
Senior research associate, Pharmacology department,
Zydus research centre, Ahemadabad, Gujarat |
| 8 |
Dr. Vishwadeep Shelke
(Supervisor) |
Inflammation targeted pharmacotherapy for diabetic acute kidney injury: Exploring novel combinations |
6th June 2024 |
Postdoctoral fellow, Department of Physiology, School of Medicine, Tulane University, New Orleans, LA, United States |
| 9 |
Dr. Prabhjeet Singh
(Co-supervisor)
|
Actively targeted nano-carrier system for the co-delivery of temozolomide and an autophagy modulator for the treatment of glioblastoma multiforme |
13th Sept 2024 |
--- |
An Institute of Eminence
